New Drug Assignments and Reassignments for 2010
- Liraglutide (Victoza®); Novo Nordisk; For the treatment of type 2 diabetes mellitus - AHFS Class: 68:20.92 (Jan, 2010)
- Tocilizumab (Actemra®); Genentech; For the treatment of rheumatoid arthritis - AHFS Class: 92:36 (Jan, 2010)
- Dalfampridine (Ampyra®); Acorda; For the improvement of walking in patients with multiple sclerosis - AHFS Class: 92:92 (Jan, 2010)
AHFS Classification Changes for 2010
The following table describes changes to the AHFS Pharmacologic-Therapeutic Classification© that will go into effect
with the publication of the 2010 edition of AHFS Drug Information® (February 1, 2010). This is only a partial listing
of the AHFS PTC. The full classification system, along with a list of drugs covered in AHFS DI and their
corresponding classes, is available in the printed edition and is available electronically in a separate file. Please contact
the ASHP Marketing and Sales Office for licensing information at
301-664-8757 or marketing@ashp.org.
| AHFS Class |
Retired |
Change Description |
12:16.04
|
- |
New classification (α-Adrenergic Blocking Agents) |
12:16.04.04
|
- |
New classification (Non-selective α-Adrenergic Blocking Agents) |
12:16.04.08
|
- |
New classification (Non-selective α1-Adrenergic Blocking Agents) |
12:16.04.12
|
- |
New classification (Selective α1-Adrenergic Blocking Agents) |
12:16.08
|
- |
New classification (β-Adrenergic Blocking Agents) |
12:16.08.04
|
- |
New classification (Non-selective β-Adrenergic Blocking Agents) |
12:16.08.08
|
- |
New classification (Selective β-Adrenergic Blocking Agents) |
28:40
|
- |
New classification (Fibromyalgia Agents) |
All material distributed as part of AHFS Drug Information is copyrighted. Reproduction, storage on a retrieval system, or
transmission of this material or any part thereof in any form or by any means without the express written permission of the
American Society of Health-System Pharmacists is prohibited.
Please contact ASHP eHealth Solutions Division at +1 (301) 664-8647 for more detailed information.
© Copyright, 2010, American Society of Health-System Pharmacists, Inc. All Rights Reserved.